Cerebral protection during transcatheter aortic valve implantation in an extreme high-risk patient.

Eur J Cardiothorac Surg

Department of Cardiovascular Surgery, German Heart Center Munich, Clinic at the Technical University, Munich, Germany.

Published: November 2017

Stroke during transcatheter aortic valve replacement is one of the most feared complications. New technologies have been developed, attempting to prevent cerebral embolization of thrombotic and calcific debris. We report a 78-year-old patient (EuroSCORE log 45.6%, STS Stroke Score 5.1%) with calcific aortic stenosis at particular risk for cerebrovascular accidents. The patient underwent transapical transcatheter aortic valve replacement using the dual filter-based Claret Sentinel™ Device for cerebral protection. Claret Sentinel Device use was associated with capture of macroscopic debris. Postoperatively, no neurological deficits could be detected by the National Institutes of Health Stroke Scale and modified Rankin scale.

Download full-text PDF

Source
http://dx.doi.org/10.1093/ejcts/ezx226DOI Listing

Publication Analysis

Top Keywords

transcatheter aortic
12
aortic valve
12
cerebral protection
8
valve replacement
8
protection transcatheter
4
aortic
4
valve implantation
4
implantation extreme
4
extreme high-risk
4
high-risk patient
4

Similar Publications

In the valve-in-valve transcatheter aortic valve replacement (ViV-TAVR) era, implanting a larger-sized valve during the initial aortic valve replacement is important. For smaller aortic annuli, combining aortic annular and left ventricular outflow tract (LVOT) enlargement is essential. The Y-incision procedure helps achieve implantation of a 2-size larger valve.

View Article and Find Full Text PDF

Transcatheter Bailout: An Important Option During Complex Aortic Surgery.

Ann Thorac Surg Short Rep

December 2024

Division of Adult Cardiothoracic Surgery, Department of Surgery, University of California, San Francisco, San Francisco, California.

This report presents the case of a 66-year-old man with acute torrential aortic insufficiency after a Ross procedure 20 years earlier, a biologic aortic valve replacement 16 years earlier, and a transcatheter valve-in-valve 4 years earlier. He underwent third-time sternotomy, revealing that the pulmonary autograft was heavily calcified and frozen to the homograft. The previous transcatheter valve-in-valve was explanted.

View Article and Find Full Text PDF

We report a case of a woman who underwent mitral ring and tricuspid annuloplasty. Two months later, she presented with acute heart failure secondary to severe aortic regurgitation, which was a complication of the cardiac surgery. Given the high surgical risk of reoperation in this the patient, she underwent transcatheter aortic valve implantation, with a good result.

View Article and Find Full Text PDF

A 90-year-old man received a diagnosis of ascending aortic pseudoaneurysms after transcatheter aortic valve implantation (TAVI) using an Evolut PRO valve (Medtronic). Plug closure of the pseudoaneurysms was successfully performed, and the symptoms improved after the procedure. However, on postoperative day 4, the patient experienced sudden massive hemoptysis and died.

View Article and Find Full Text PDF

Background: Continuous retrograde flow across the aortic valve from left ventricular assist device (LVAD) therapy can result in cusp damage and progressive aortic regurgitation, potentially triggering recurrent heart and multiorgan failure. The management of aortic regurgitation after LVAD implantation has not been well defined.

Methods: This study retrospectively reviewed the investigators' experience with the management of de novo aortic regurgitation requiring intervention in patients with continuous-flow LVAD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!